Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden. [PDF]
Espinosa-Gongora C +11 more
europepmc +1 more source
Mpox Epidemics: A Call to Restore Humanity's Lost Herd Immunity to Orthopoxviruses. [PDF]
Wayengera M +11 more
europepmc +1 more source
Emerging threats of monkeypox virus in 2024: current insights and future directions. [PDF]
L S D +7 more
europepmc +1 more source
Sero-neutralizing antibody against orthopoxviruses in populations of Wuhan, China. [PDF]
Gao Z, Liu T, Zhao Z, Wang B, Hou L.
europepmc +1 more source
Neurological complications of Orthopoxvirus infections: neurotropism and neurovirulence. [PDF]
Miranzadeh Mahabadi H +3 more
europepmc +1 more source
Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks. [PDF]
Orkin C +4 more
europepmc +1 more source
Outbreak dates of virus could be predicted by their protein sequence. [PDF]
Zuo P +10 more
europepmc +1 more source
Machine learning-supported framework for the classification of mpox infection and MVA immunization from multiplexed serology data. [PDF]
Surtees R +21 more
europepmc +1 more source
A review of vaccinology and <i>ex vivo</i> antigen-loaded dendritic cells: A different approach to infectious disease vaccines. [PDF]
Dillman RO, Nistor GI, Keirstead HS.
europepmc +1 more source

